In such case, it might be interesting to investigate whether unchanged methylation in the BDNF exon IV promoter in adolescent depression could be associated with worse disease course in the future and therefore verify the usefulness of decreased methylation in the BDNF exon IV promoter as a prognostic biomarker of depression. Here, BDNF is linked to major depressive disorder.